Klinische Studie

Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer

NCT: NCT06667752 · ACTIVE_NOT_RECRUITING

NCT-IDNCT06667752

Medizinische Daten: StatusACTIVE_NOT_RECRUITING

Startdatum2024-10-17

Abschluss2026-12-31

SponsorNanordica Medical OU (INDUSTRY)

First posted2024-10-31

Last updated2026-09-18

Kurzzusammenfassung

This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 136 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.